| Susan P. Wright History of Science, University of Michigan Residential College, East Quadrangle Ann Arbor, Michigan 48109-1245 (734) 763-1194 spwright@umich.edu Home Page |
Richard Falk Center of International Studies Princeton University Princeton, New Jersey 08544 rfalk@princeton.edu |
| Research Associate: Romica Singh singhr@umich.edu |
A critical problem facing the parties to the Biological Weapons Convention
is
that of providing access to the biological sciences and biotechnology for
peaceful purposes while ensuring that states comply with the treaty's
prohibition of the development, production and stockpiling of biological
and
toxin weapons. This project, under the sponsorship of the UN Institute for
Disarmament Research, examines the present barriers to achieving such a
balance
and approaches to overcoming them.
Since the Third Review Conference of the Convention, held in 1991, efforts
of
the member states to strengthen the Convention have concentrated on
developing a
legally binding protocol to the BWC designed to increase confidence in
compliance. But progress has been slow. There are strong technical and
political
disagreements on what can be achieved through verification, extending even
to
the meaning of verification. Some point to the difficulties in achieving
closure
on the extent of Iraq's biological weapons program as an indicator of the
technical problems posed by any attempt to verify compliance. Some believe
these
difficulties can be overcome by detailed declarations and an intrusive
inspection regime. At the same time, some corporate members of the
biotechnology
industry urge stringent limits on declarations and inspections on the
grounds
that transparency endangers intellectual property. Given these apparently
contradictory interests, can verification of compliance with the
Biological
Weapons Convention be made to work? What other approaches to strengthening
the
BW regime can be taken, outside as well as inside the framework of the
Convention?
A further question related to strengthening the BWC concerns article X,
which
calls upon parties to the treaty to "undertake [to facilitate] the
fullest
possible exchange of equipment, materials and scientific and technological
information for the use of biological agents and toxins for peaceful
purposes." Since the early 1970s when the Convention was negotiated,
the
development of intellectual property rights in the field of biotechnology
has
restricted the informal sharing of knowledge, techniques, and samples that
characterized the biological sciences in the 1960s. This is the case not
only
within the industrialized north but also between the industrialized north
and
the developing south. Does the restriction of access of developing
countries to
biological resources and equipment remove the possibility of using article
X as
a source of incentives for supporting a strengthened BW regime?
These questions of political and technical feasibility and incentives
signal an
important need for reappraisal of the present approaches to strengthening
the
Biological Weapons Convention. This project aims to bring together
scholars in
relevant fields (international law, international relations, the
biological
sciences, medicine, public health, history, economics, area studies,
journalism), members of non-governmental organizations committed to
disarmament
and the peaceful development of the biological sciences, and specialists
on the
Biological Weapons Convention to address not only the immediate problems
facing
the BWC but also the larger political, military, and economic contexts of
the
Convention and how positions on biological disarmament are affected by
them. A
further major goal is to achieve broad geographical, and especially
non-western,
representation, and to provide a space where non-western perspectives can
be
seriously presented and discussed.
In summary, the project aims to understand the present barriers to
strengthening
the biological disarmament regime and to move beyond them. This may well
involve
a broad reconceptualization of the present problems and projected
solutions.
The project is supported by grants from the John D. and Catherine T.
MacArthur
Foundation, the Ford Foundation, the New England Biolabs Foundation, and
the
University of Michigan.